# BrightGene Pharmaceutical Co., Ltd. – FDA Inspection, Dec 8, 2017

Source: https://www.keypedia.com/records/fda_inspections/brightgene-pharmaceutical-co-ltd/ee9f58ae-6c34-45c4-8be2-1150961abf5f
Source feed: FDA_Inspections

> FDA inspection 1038967 of BrightGene Pharmaceutical Co., Ltd., December 08, 2017. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038967
- Company Name: BrightGene Pharmaceutical Co., Ltd.
- Inspection Date: 2017-12-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1240231 - 2024-04-26
- FDA Inspection 942083 - 2015-09-10
- FDA Inspection 831367 - 2013-03-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/steven-p-donald/431cb518-7687-408b-82e4-e525a135a26b)

Company: https://www.keypedia.com/companies/brightgene-pharmaceutical-co-ltd/532f1ca2-79a4-40bb-bf0e-3869fc8a2213

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c